Hilzenrat, R.A.; Yip, S.; Melosky, B.; Ho, C.; Laskin, J.; Sun, S.; Choi, J.J.; McGuire, A.L.
Disparate Time-to-Treatment and Varied Incidence of Actionable Non-Small Cell Lung Cancer Molecular Alterations in British Columbia: A Historical Cohort Study. Curr. Oncol. 2023, 30, 145-156.
https://doi.org/10.3390/curroncol30010012
AMA Style
Hilzenrat RA, Yip S, Melosky B, Ho C, Laskin J, Sun S, Choi JJ, McGuire AL.
Disparate Time-to-Treatment and Varied Incidence of Actionable Non-Small Cell Lung Cancer Molecular Alterations in British Columbia: A Historical Cohort Study. Current Oncology. 2023; 30(1):145-156.
https://doi.org/10.3390/curroncol30010012
Chicago/Turabian Style
Hilzenrat, Roy Avraham, Stephen Yip, Barbara Melosky, Cheryl Ho, Janessa Laskin, Sophie Sun, James J. Choi, and Anna L. McGuire.
2023. "Disparate Time-to-Treatment and Varied Incidence of Actionable Non-Small Cell Lung Cancer Molecular Alterations in British Columbia: A Historical Cohort Study" Current Oncology 30, no. 1: 145-156.
https://doi.org/10.3390/curroncol30010012
APA Style
Hilzenrat, R. A., Yip, S., Melosky, B., Ho, C., Laskin, J., Sun, S., Choi, J. J., & McGuire, A. L.
(2023). Disparate Time-to-Treatment and Varied Incidence of Actionable Non-Small Cell Lung Cancer Molecular Alterations in British Columbia: A Historical Cohort Study. Current Oncology, 30(1), 145-156.
https://doi.org/10.3390/curroncol30010012